Genetic mutation predicts pancreatic cancer metastasis and survival

A new study by Mayo Clinic Comprehensive Cancer Center researchers found that the presence of a specific genetic mutation—KRAS circulating tumor DNA (ctDNA)—strongly indicates a higher risk of cancer spread and worse survival rates for patients with pancreatic ductal adenocarcinoma (PDAC). The mutation was identified using a readily available and clinically approved blood and abdominal fluid test.

Portland Protesters ATTACK Federal Agents — Protesters NOT Arrested!
- Boredom Is A Superpower - Robert Scucci
- Best Side Hustles and Service Businesses with Financial Analysis & Investment Strategy Skills - Zoul
- Woman wins $100K Powerball prize after asking ChatGPT what numbers to play
- Women with large preterm infants may have higher risk of cardiovascular disease later in life
- Piers Morgan Explodes at Prince Harry, Calls Him ‘Drug-Addled Little Twerp’ After Explosive BBC Interview - Isaiah Amos
- This is how the new ranching system will work in Cult of the Lamb: Woolhaven

This 5-Minute Fix Could Save You Thousands on Medicare
- RFK Jr.’s MAHA wants to make chemtrail conspiracy theories great again - Beth Mole
- Decoding the Enigma of the Snowball Earth - Arya Chandran
- Key to a long life? World's oldest woman may have answer for her 117 years
- Tom Cruise’s Best Sci-Fi Thriller Is Waiting For You On Netflix - Robert Scucci
- How Magnesium Citrate Can Take Care of Your Constipation in Just 30 Minutes - Kirstyn Hill, PharmD, MPH
- WATCH: Reform UK Mayor STORMS OUT of Interview After BRUTAL GRILLING – Political KNIVES Are OUT in Shock Showdown - Isaiah Amos